Market revenue in 2023 | USD 58.8 million |
Market revenue in 2030 | USD 87.4 million |
Growth rate | 5.8% (CAGR from 2023 to 2030) |
Largest segment | Transvenous implantable cardioverter-defibrillators |
Fastest growing segment | Subcutaneous Implantable Cardioverter Defibrillators |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Transvenous Implantable Cardioverter-Defibrillators, Subcutaneous Implantable Cardioverter Defibrillators |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, BIOTRONIK, Boston Scientific Corp, MicroPort Scientific Corp, LivaNova PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to implantable cardioverter defibrillators market will help companies and investors design strategic landscapes.
Transvenous implantable cardioverter-defibrillators was the largest segment with a revenue share of 89.63% in 2023. Horizon Databook has segmented the Mexico implantable cardioverter defibrillators market based on transvenous implantable cardioverter-defibrillators, subcutaneous implantable cardioverter defibrillators covering the revenue growth of each sub-segment from 2018 to 2030.
As per the American College of Cardiology Foundation, CVD poses a significant threat in Mexico, leading to the loss of 1 life every 2 minutes. In 2021, the Mexican government confirmed an alarming number of approximately 226,000 deaths caused by CVDs, surpassing the number of deaths caused by COVID-19.
This data highlights CVDs immense burden in Mexico and emphasizes the need for reliable diagnosis & treatment options. Hence, devices such as ICDs are crucial in providing effective interventions and potentially saving lives. The demand for ICDs is expected to rise in Mexico as the healthcare system strives to address the growing prevalence of CVDs and improve patient outcomes.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico implantable cardioverter defibrillators market , including forecasts for subscribers. This country databook contains high-level insights into Mexico implantable cardioverter defibrillators market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account